<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1542892141738">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">22.11.2018 13:09:01 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.16jiqs74og672</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>Another year &lt;a href=&quot;http://stsmihajlopupin.edu.rs/rs/kroger-pharmacy-jobs-memphis-tn-3c56.pdf#wasteful&quot;&gt;kroger pharmacy toledo ohio monroe and secor&lt;/a&gt;  The study included 26,180 patients and 92,241 swabs were collected to determine the acquisition of MRSA and VRE. The primary outcome was the acquisition of MRSA or VRE based on cultures collected on admission and discharge from ICU, and there was no difference between the control and intervention arms for this outcome. However, for the secondary outcomes, although there was no difference in VRE acquisition, there was a 40% reduction in MRSA acquisition.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
